stella
beta
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children — Stella
Home
/
Focal Segmental Glomerulosclerosis
/
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
View on ClinicalTrials.gov
Recruiting
Back to Focal Segmental Glomerulosclerosis trials
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(12 sites)
United States
Loma Linda University Children's Hospital, Loma Linda, California
Cedars Sinai Medical Center, Los Angeles, California
Nemours/A.I. duPont Hospital for Children, Wilmington, Delaware
Nemours Children's Health, Orlando, Florida
Helen DeVos Children's Hospital, Grand Rapids, Michigan
University of Minnesota, Minneapolis, Minnesota
Weill Cornell Medical Center / NewYork-Presbyterian, New York, New York
University of North Carolina, Chapel Hill, North Carolina
Akron Children's Hospital, Akron, Ohio
St. Christopher's Hospital for Children, Philadelphia, Pennsylvania
Medical University of South Carolina Children's Hospital, Charleston, South Carolina
Children's Hospital of Richmond at VCU, Richmond, Virginia